Literature DB >> 35320503

Clinical characteristics and the diagnostic role of molecular tests in musculoskeletal infections caused by nontuberculous Mycobacterium: a single-center experience.

Cheon Hoo Jeon1, Si-Ho Kim1, Hae Suk Cheong2, Dong Hee Kim3, Yu-Ji Lee1, Eun Phil Heo4, Yu Mi Wi5.   

Abstract

PURPOSE: We retrospectively investigated NTM musculoskeletal infections to understand the clinical characteristics as well as the diagnostic performance of molecular tests as a useful supplementary test.
METHODS: A retrospective cohort study was conducted from January 2016 to December 2019. Intraoperative specimens for culture and pathological analysis were obtained during surgery under sterile conditions. AdvanSure TB/NTM real-time PCR (LG Life Sciences, Seoul, Korea) and PCR-reverse blot hybridization assay (REBA, REBA Myco-ID; YD Diagnostics, Yongin, Republic of Korea) was performed directly from tissue specimens for the rapid and accurate identification of 20 mycobacterial species.
RESULTS: A series of 24 patients was identified during the study period. Agricultural/aquatic exposure were predisposing factors in 9 patients, trauma in 4 patients, but no predisposing host factor was identified for 11 patients. Twenty-two patients presented with tenosynovitis and two with arthritis with substantial delays between initial presentation of symptoms and microbiologic diagnosis, with a median of 147 days (range 5-396 days). Pathologic tissue examination of musculoskeletal NTM infections was positive for chronic granulomatous inflammation in 18 cases. Fifteen were positive in the culture study, and nine were positive only in the molecular study using tissue specimens. All 6 M. ulcerans/M. marinum isolates were identified only by PCR.
CONCLUSIONS: This study is an important reminder that NTM infections should be a part of the differential diagnosis in patients with chronic musculoskeletal infections refractory to regular treatment. Although molecular test cannot replace the conventional smear and culture methods, it can be used as a useful supplementary test especially in diagnosing M. marinum infection.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Identification; NTM; Nontuberculous mycobacteria; Polymerase chain reaction; Tenosynovitis

Mesh:

Year:  2022        PMID: 35320503     DOI: 10.1007/s15010-022-01780-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  10 in total

1.  Evaluation of PCR-reverse blot hybridization assay for the differentiation and identification of Mycobacterium species in liquid cultures.

Authors:  H-Y Wang; H Kim; S Kim; H Bang; D-K Kim; H Lee
Journal:  J Appl Microbiol       Date:  2014-11-21       Impact factor: 3.772

Review 2.  Aquarium-borne Mycobacterium marinum skin infection. Report of 15 cases and review of the literature.

Authors:  Domenico Bonamonte; Daniela De Vito; Michelangelo Vestita; Susanna Delvecchio; Luigi Davide Ranieri; Marilina Santantonio; Gianni Angelini
Journal:  Eur J Dermatol       Date:  2013 Jul-Aug       Impact factor: 3.328

3.  Non-tuberculous mycobacterial infection of the musculoskeletal system: pattern of infection and efficacy of combined surgical/antimicrobial treatment.

Authors:  J W Park; Y S Kim; J O Yoon; J S Kim; J S Chang; J M Kim; J M Chun; I H Jeon
Journal:  Bone Joint J       Date:  2014-11       Impact factor: 5.082

4.  Paradigm for diagnosing mycobacterial disease: direct detection and differentiation of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria in clinical specimens using multiplex real-time PCR.

Authors:  Jeong-Uk Kim; Dae-Shick Ryu; Choong-Hwan Cha; Seon-Hee Park
Journal:  J Clin Pathol       Date:  2018-03-20       Impact factor: 3.411

5.  Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.

Authors:  Sarah K Brode; Alex Marchand-Austin; Frances B Jamieson; Theodore K Marras
Journal:  Emerg Infect Dis       Date:  2017-11       Impact factor: 6.883

6.  Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007-2012.

Authors:  Emily Henkle; Katrina Hedberg; Sean D Schafer; Kevin L Winthrop
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

7.  Nontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century.

Authors:  Thomas S Hermansen; Pernille Ravn; Erik Svensson; Troels Lillebaek
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

8.  Nontuberculous Mycobacterial Musculoskeletal Infection Cases from a Tertiary Referral Center, Colorado, USA.

Authors:  Noah Goldstein; J Benjamin St Clair; Shannon H Kasperbauer; Charles L Daley; Bennie Lindeque
Journal:  Emerg Infect Dis       Date:  2019-06       Impact factor: 6.883

Review 9.  Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.

Authors:  Yu Mi Wi
Journal:  Infect Chemother       Date:  2019-09

10.  Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009-2014.

Authors:  Emily E Ricotta; Jennifer Adjemian; Rebekah A Blakney; Yi Ling Lai; Sameer S Kadri; D Rebecca Prevots
Journal:  Emerg Infect Dis       Date:  2021-03       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.